EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sodium Stearate-Assisted Optimization of a Cannabidiol Dry Powder Inhaler for Enhanced Dissolution and Aerosol Performance

Jin-Hyuk Jeong, Jae Seok Jeong iD, Hyeon-Seo Moon, Jae Woon Son iD, Kyung Hyun Min iD, Dong-Wook Kim, Chang-Soo Han, Wonwoong Lee, Chun-Woong Park iD, Ji-Hyun Kang iD

Pharmaceutics · 21.04.2026 · 18 (4) · 512

DOI: 10.3390/pharmaceutics18040512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 21.04.2026. Verfasst von Jin-Hyuk Jeong und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, Jeonbuk National University, Daewoong Pharmaceutical (South Korea).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cannabidiol (CBD) has emerged as a potential therapeutic agent for respiratory disorders, including asthma and chronic obstructive pulmonary disease. However, its clinical translation via pulmonary delivery is limited by poor aqueous solubility, chemical instability, and low local bioavailability. This study aimed to develop and optimize a sodium stearate (NaSt)-based spray-dried dry powder inhaler (DPI) formulation to enhance the aerosol performance, dissolution, and storage stability of CBD.

Methods

CBD microparticles were prepared by spray drying using NaSt as the primary excipient. The feed preparation method, spray-drying parameters, and CBD:NaSt ratios were systematically optimized. The resulting powders were evaluated for aerodynamic properties using cascade impaction, dissolution behavior in simulated lung fluid, solid-state characteristics, and accelerated stability under stress conditions.

Results

The optimized formulation, SD-4, a spray-dried CBD:NaSt formulation prepared at a 20:80 weight ratio using Process B, demonstrated excellent aerosolization performance, with a fine particle fraction (FPF) exceeding 50% and a mass median aerodynamic diameter (MMAD) of 5.08 ± 0.1 μm. Dissolution testing revealed more than a three-fold increase in drug release compared with raw CBD, attributed to amorphous dispersion within the NaSt matrix and surfactant-induced micellization. Accelerated stability studies confirmed improved retention of the amorphous state and drug content, while antioxidant incorporation further reduced oxidative degradation.

Conclusions

The NaSt-based spray-dried formulation significantly improved aerosol deposition efficiency, dissolution rate, and physicochemical stability of CBD. This formulation strategy may provide a promising platform for pulmonary delivery of poorly water-soluble compounds.

Schlagwörter

Stichwörter der Autor:innen

aerosol performanceamorphous dispersionmicellizationoxidative stabilitysolubility enhancement

Autor:innen und Institutionen

  • College of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
  • Korea Zoonosis Research Institute, Jeonbuk National University, Iksan 54531, Republic of Korea.
  • Department of Internal Medicine, Research Center for Pulmonary Disorders, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
  • Respiratory Drug Development Research Institute, Jeonbuk National University, Jeonju 54928, Republic of Korea.
  • School of Pharmacy, Jeonbuk National University, Jeonju 54928, Republic of Korea.
  • Institute of New Drug Development, Jeonbuk National University, Jeonju 54928, Republic of Korea.

ORCID-Profile: Jae Seok Jeong, Jae Woon Son, Kyung Hyun Min, Chun-Woong Park, Ji-Hyun Kang

Förderung

  • Ministry of Trade, Industry and Energy
  • Jeonbuk National University
  • Daewoong Pharmaceutical (South Korea)
  • Ministry of Science and ICT
  • Ministry of Health and Welfare
  • Ministry of Trade, Industry & Energy
  • Daewoong Foundation
  • National Research Foundation of Korea

Zitieren

APA

Jeong, J. H., Jeong, J. S., Moon, H. S., Son, J. W., Min, K. H., Kim, D. W., Han, C. S., Lee, W., Park, C. W., & Kang, J. H. (2026). Sodium Stearate-Assisted Optimization of a Cannabidiol Dry Powder Inhaler for Enhanced Dissolution and Aerosol Performance. Pharmaceutics, 18(4), 512. https://doi.org/10.3390/pharmaceutics18040512

Vancouver

Jeong JH, Jeong JS, Moon HS, Son JW, Min KH, Kim DW, et al. Sodium Stearate-Assisted Optimization of a Cannabidiol Dry Powder Inhaler for Enhanced Dissolution and Aerosol Performance. Pharmaceutics. 2026;18(4):512. doi:10.3390/pharmaceutics18040512

BibTeX
@article{Jeong2026,
  author = {Jeong, Jin-Hyuk and Jeong, Jae Seok and Moon, Hyeon-Seo and Son, Jae Woon and Min, Kyung Hyun and Kim, Dong-Wook and Han, Chang-Soo and Lee, Wonwoong and Park, Chun-Woong and Kang, Ji-Hyun},
  title = {Sodium Stearate-Assisted Optimization of a Cannabidiol Dry Powder Inhaler for Enhanced Dissolution and Aerosol Performance},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {512},
  doi = {10.3390/pharmaceutics18040512}
}
Kostenlos starten →